iTeos Therapeutics, Inc.

NasdaqGM:ITOS

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

United States

Market Cap

USD 446.57 M

Share Price

USD 10.11

Avg Daily Volume

1,726,424

Change (1 day)

-0.20%

Change (1 year)

-32.51%

Change (YTD)

31.64%

iTeos Therapeutics, Inc. Common Stock Issued for the Trailing 12 Months (TTM) ending December 31, 2024: USD 119.99 M

iTeos Therapeutics, Inc. Common Stock Issued is USD 119.99 M for the Trailing 12 Months (TTM) ending December 31, 2024. Common stock issued is cash received from issuing new shares of the company’s common stock.

Competitors

Eli Lilly and Company

USD 625.65

LLY

-15.21 -2.37%

AbbVie Inc.

USD 198.05

ABBV

-0.81 -0.41%

Roche Holding AG

USD 318.77

RO.SW

-3.47 -1.08%

AstraZeneca PLC

USD 150.15

AZN.L

-2.01 -1.32%

Novartis AG

USD 116.31

NOVN.SW

+1.16 1.00%

Novo Nordisk A/S

USD 50.40

NOVO-B.CO

+2.25 4.67%

Merck & Co., Inc.

USD 80.69

MRK

+0.32 0.40%

Thermo Fisher Scientific Inc.

USD 460.72

TMO

+5.98 1.31%

Amgen Inc.

USD 288.23

AMGN

+3.53 1.24%

Pfizer Inc.

USD 24.58

PFE

+0.35 1.44%

Gilead Sciences, Inc.

USD 119.41

GILD

+9.13 8.28%

Sanofi

USD 94.22

SAN.PA

-0.08 -0.08%

Vertex Pharmaceuticals Incorporated

USD 366.54

VRTX

-9.09 -2.42%

Bristol-Myers Squibb Company

USD 45.95

BMY

+0.59 1.30%

Chugai Pharmaceutical Co., Ltd.

USD 41.22

4519.T

-9.07 -18.03%

View all

Key Data

Date	Common Stock Issued	Common Stock Repurchased	Free Cash Flow	Operating Cash Flow